# ClinicalIntelPulse Sponsor Pipeline Intelligence

> ClinicalIntelPulse Sponsor Pipeline Intelligence is a paid API for AI agents from clinicalintelpulse.theaslangroupllc.com, paid per call via x402, $0.2/call, status unknown (last checked 2026-09-14).

Returns a comprehensive drug pipeline intelligence report for a given pharma/biotech sponsor — covering pipeline phases, therapeutic areas, FDA approval history, partnerships, competitive positioning, and investment catalysts.

## Facts

- Endpoint: GET https://clinicalintelpulse.theaslangroupllc.com/api/clinical/sponsor-intel
- Price: $0.2/call
- Payment: x402
- Status: unknown
- Last checked: 2026-09-14
- Activations on Zero: 0
- Tags: x402
- Canonical page: https://www.zero.xyz/c/clinicalintelpulse-sponsor-pipeline-intelligence-54525278
- Structured record (JSON): https://api.zero.xyz/v1/capabilities/cap_NJxGiEC4IYsNPcRCLrEjY

Status and success rate cover calls made through Zero and Zero's own probes. Third-party monitors may report differently.

## How to call it through Zero

Zero handles the 402 payment challenge and records the run. With the Zero CLI installed (`npm i -g @zeroxyz/cli`):

```sh
zero fetch --capability clinicalintelpulse-sponsor-pipeline-intelligence-54525278
```

Example prompt: Pull the full pipeline intelligence report for Vertex Pharmaceuticals — I want their drug pipeline broken down by clinical phase, therapeutic area coverage, FDA approval history, any major partnerships, and the top investment catalysts I should be watching.

## When to prefer this

Use this endpoint when you need a comprehensive, sponsor-level view of a pharma or biotech company's pipeline for investment research, M&A due diligence, or competitive benchmarking. Prefer this over disease-level endpoints when the research question centers on a specific company rather than a therapeutic area or disease. Ideal for investor agents, equity analysts, and M&A teams that need a rapid 360-degree view of a sponsor's clinical and regulatory standing.

## Known failure modes

- Unknown or misspelled sponsor name returns empty or low-confidence results
- Small or private sponsors with limited public trial data may return sparse pipelines
- Recently renamed or merged companies may not match historical records
- Non-English or non-Romanized sponsor names may require normalization
- Rate limiting or payment failure may return 402/429 errors

## How this service works

Pharma/biotech company pipeline intelligence — full drug pipeline by phase, therapeutic-area coverage, FDA approval history, partnerships, competitive positioning and investment catalysts for any sponsor. Worldwide. For investor and M&A agents.

## Output

A structured intelligence report for the requested sponsor including: full drug pipeline organized by clinical phase (Phase 1 through NDA/BLA), therapeutic area coverage map, historical FDA/EMA approval track record, active and recent partnerships or licensing deals, competitive positioning narrative, and near-term investment catalysts — all sourced from global clinical registries and regulatory databases.

## Request schema (JSON Schema)

```json
{
 "type": "object",
 "$schema": "https://json-schema.org/draft/2020-12/schema",
 "required": [
  "input"
 ],
 "properties": {
  "input": {
   "type": "object",
   "required": [
    "type",
    "method"
   ],
   "properties": {
    "type": {
     "type": "string",
     "const": "http"
    },
    "method": {
     "enum": [
      "GET",
      "HEAD",
      "DELETE"
     ],
     "type": "string"
    },
    "queryParams": {
     "type": "object",
     "properties": {
      "lang": {
       "type": "string"
      },
      "focus": {
       "type": "string"
      },
      "sponsor": {
       "type": "string"
      }
     }
    }
   },
   "additionalProperties": false
  },
  "output": {
   "type": "object",
   "required": [
    "type"
   ],
   "properties": {
    "type": {
     "type": "string"
    },
    "errors": {
     "type": "object",
     "description": "Documented error responses, keyed by HTTP status code",
     "additionalProperties": {
      "type": "object",
      "required": [
       "description"
      ],
      "properties": {
       "example": {
        "type": "object"
       },
       "description": {
        "type": "string"
       }
      }
     }
    },
    "example": {
     "type": "object"
    }
   }
  }
 }
}
```

## Response schema (JSON Schema)

```json
{
 "type": "json",
 "example": {
  "fda_approvals": [
   {
    "drug": "Patisiran (Onpattro)",
    "type": "NDA",
    "approved": "2018",
    "indication": "hATTR polyneuropathy",
    "first_in_class": true
   },
   {
    "drug": "Givosiran (Givlaari)",
    "type": "NDA",
    "approved": "2019",
    "indication": "Acute hepatic porphyria"
   }
  ],
  "phase3_assets": [
   {
    "drug": "Vutrisiran (Amvuttra)",
    "nctId": "NCT04153149",
    "status": "ACTIVE_NOT_RECRUITING",
    "condition": "ATTR Cardiomyopathy",
    "completion": "2025-Q3",
    "significance": "Key label expansion into ATTR-CM — $3B+ market"
   }
  ],
  "query_summary": {
   "focus": "all",
   "sponsor": "Alnylam Pharmaceuticals"
  },
  "pipeline_summary": {
   "phase1_count": 8,
   "phase2_count": 9,
   "phase3_count": 6,
   "total_active_trials": 23,
   "primary_therapeutic_areas": [
    "Rare genetic diseases (TTR, PH1, AHP)",
    "Cardiovascular (inclisiran)",
    "CNS (Huntington's)"
   ]
  },
  "investment_signals": {
   "risks": [
    "Pricing pressure in rare disease",
    "RNAi delivery competition from Arrowhead"
   ],
   "near_term_catalysts": [
    "HELIOS-B ATTR-CM readout 2025",
    "ALN-APP Phase 2 for early Alzheimer's"
   ],
   "pipeline_value_estimate": "$12-18B risk-adjusted NPV"
  },
  "competitive_position": "Global leader in RNAi therapeutics. 6 approved drugs. Patent portfolio dominant through 2035+.",
  "partnership_activity": "Novartis partnership (inclisiran, cardiovascular) — $9.7B deal. Roche collaborations ongoing. Regeneron RNAi collaboration $400M+."
 }
}
```

## More

- Live health (JSON, refreshed every minute): https://www.zero.xyz/c/clinicalintelpulse-sponsor-pipeline-intelligence-54525278/health.json
- [Zero catalog index](https://www.zero.xyz/llms.txt)
- [Other services from clinicalintelpulse.theaslangroupllc.com](https://www.zero.xyz/host/clinicalintelpulse.theaslangroupllc.com/llms.txt)